Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Current perspectives on the treatment of rheumatic diseases with infliximab

How does infliximab work in rheumatoid arthritis?

Ravinder N Maini* and Marc Feldmann

Arthritis Res 2002, 4(Suppl 2):S22-S28 doi:10.1186/ar549

Accesses  

  • Last 30 days: 200 accesses
  • Last 365 days: 2065 accesses
  • All time: 17943 accesses

Cited by

BioMed Central: 5 citations

Editorial   Free Highly Accessed

Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis

Maria J Leandro Arthritis Research & Therapy 2009, 11:128 (6 October 2009)

Research article   Open Access Highly Accessed

Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor

M Margarida Souto-Carneiro, Vijayabhanu Mahadevan, Kazuki Takada, Ruth Fritsch-Stork, Toshihiro Nanki, Margaret Brown, Thomas A Fleisher, Mildred Wilson, Raphaela Goldbach-Mansky, Peter E Lipsky Arthritis Research & Therapy 2009, 11:R84 (5 June 2009)

Review   Free Highly Accessed

Effective use of TNF antagonists

David Yocum Arthritis Res Ther 2004, 6(Suppl 2):S24-S30 (21 June 2004)

Review   Free Highly Accessed

Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?

Sergio Schwartzman, Roy Fleischmann, G James Morgan Arthritis Res Ther 2004, 6(Suppl 2):S3-S11 (21 June 2004)

Review   Free

Current and new antitumor necrosis factor agents in perspective

Ravinder N Maini Arthritis Res Ther 2004, 6(Suppl 2):S1-S2 (21 June 2004)